227 related articles for article (PubMed ID: 16473763)
1. Angiogenesis: the VE-cadherin switch.
Wallez Y; Vilgrain I; Huber P
Trends Cardiovasc Med; 2006 Feb; 16(2):55-9. PubMed ID: 16473763
[TBL] [Abstract][Full Text] [Related]
2. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium.
Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC
Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935
[TBL] [Abstract][Full Text] [Related]
4. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
5. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cadherins and tumor angiogenesis.
Cavallaro U; Liebner S; Dejana E
Exp Cell Res; 2006 Mar; 312(5):659-67. PubMed ID: 16256984
[TBL] [Abstract][Full Text] [Related]
7. VE-cadherin increases the half-life of VEGF receptor 2.
Calera MR; Venkatakrishnan A; Kazlauskas A
Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial (VE)-cadherin: only an intercellular glue?
Dejana E; Bazzoni G; Lampugnani MG
Exp Cell Res; 1999 Oct; 252(1):13-9. PubMed ID: 10502395
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G
Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602
[TBL] [Abstract][Full Text] [Related]
10. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation and the small GTPase rac cross-talk in regulation of endothelial barrier function.
Seebach J; Mädler HJ; Wojciak-Stothard B; Schnittler HJ
Thromb Haemost; 2005 Sep; 94(3):620-9. PubMed ID: 16268481
[TBL] [Abstract][Full Text] [Related]
12. Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.
Rabascio C; Muratori E; Mancuso P; Calleri A; Raia V; Foutz T; Cinieri S; Veronesi G; Pruneri G; Lampertico P; Iavarone M; Martinelli G; Goldhirsch A; Bertolini F
Cancer Res; 2004 Jun; 64(12):4373-7. PubMed ID: 15205354
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of endothelial barrier function during normal angiogenesis requires homotypic VE-cadherin adhesion.
DeFouw LM; DeFouw DO
Tissue Cell; 2000 Jun; 32(3):238-42. PubMed ID: 11037794
[TBL] [Abstract][Full Text] [Related]
14. VE-cadherin status as an indicator of microvascular permeability.
Monaghan-Benson E; Burridge K
Methods Mol Biol; 2013; 1046():335-42. PubMed ID: 23868598
[TBL] [Abstract][Full Text] [Related]
15. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
[TBL] [Abstract][Full Text] [Related]
16. [VE-cadherin takes a walk on the wild side].
Gavard J; Gutkind JS
Med Sci (Paris); 2007 Feb; 23(2):119-21. PubMed ID: 17291415
[No Abstract] [Full Text] [Related]
17. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells.
Blecharz KG; Drenckhahn D; Förster CY
J Cereb Blood Flow Metab; 2008 Jun; 28(6):1139-49. PubMed ID: 18231113
[TBL] [Abstract][Full Text] [Related]
18. Breaking the VE-cadherin bonds.
Gavard J
FEBS Lett; 2009 Jan; 583(1):1-6. PubMed ID: 19059243
[TBL] [Abstract][Full Text] [Related]
19. Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis.
Lampugnani MG; Dejana E
Thromb Res; 2007; 120 Suppl 2():S1-6. PubMed ID: 18023702
[TBL] [Abstract][Full Text] [Related]
20. HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites.
Le Bras A; Lionneton F; Mattot V; Lelièvre E; Caetano B; Spruyt N; Soncin F
Oncogene; 2007 Nov; 26(53):7480-9. PubMed ID: 17563748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
